Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

AC Immune S.A. (ACIU)

AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AC Immune: Q3 Earnings Snapshot

AC Immune: Q3 Earnings Snapshot

ACIU : 2.88 (+1.05%)
Leerink Partners Remains a Buy on AC Immune SA (ACIU)

In a report released on October 7, Marc Goodman from Leerink Partners maintained a Buy rating on AC Immune SA. The company’s shares closed yesterday at $3.48.Elevate Your Investing Strategy: Take advantage...

ACIU : 2.88 (+1.05%)
AC Immune: Q2 Earnings Snapshot

AC Immune: Q2 Earnings Snapshot

ACIU : 2.88 (+1.05%)
AC Immune: Q1 Earnings Snapshot

AC Immune: Q1 Earnings Snapshot

ACIU : 2.88 (+1.05%)
New Strong Buy Stocks for January 31st

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:EnerSys (ENS): This energy storage solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing...

ACIU : 2.88 (+1.05%)
SFIX : 4.69 (+2.85%)
MC : 66.45 (+1.85%)
SOPA : 1.5100 (+3.42%)
AC Immune Reports Positive Interim Safety Data for ACI-24.060 in Down Syndrome Phase 1b/2 ABATE Trial

AC Immune reports positive interim safety data for ACI-24.060 in Down syndrome, showing no serious adverse events noted.Quiver AI SummaryAC Immune SA announced positive interim safety data from its Phase...

ACIU : 2.88 (+1.05%)
AC Immune: Q3 Earnings Snapshot

AC Immune: Q3 Earnings Snapshot

ACIU : 2.88 (+1.05%)
AC Immune: Q2 Earnings Snapshot

AC Immune: Q2 Earnings Snapshot

ACIU : 2.88 (+1.05%)
AC Immune: Q1 Earnings Snapshot

AC Immune: Q1 Earnings Snapshot

ACIU : 2.88 (+1.05%)
AC Immune: Q3 Earnings Snapshot

AC Immune: Q3 Earnings Snapshot

ACIU : 2.88 (+1.05%)

Barchart Exclusives

Is This Dividend Stock a Buy for 2026 After Rising 265% in 2025?
Anglogold Ashanti shares have soared this year amid a spike in gold prices. While the shares might take a breather for now, it is a buy-on-the-dip candidate for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar